Literature DB >> 23134978

Loop-loop interactions involved in antisense regulation are processed by the endoribonuclease III in Staphylococcus aureus.

Cédric Romilly1, Clément Chevalier, Stefano Marzi, Benoît Masquida, Thomas Geissmann, François Vandenesch, Eric Westhof, Pascale Romby.   

Abstract

The endoribonuclease III (RNase III) belongs to the enzyme family known to process double-stranded RNAs. Staphylococcus aureus RNase III was shown to regulate, in concert with the quorum sensing induced RNAIII, the degradation of several mRNAs encoding virulence factors and the transcriptional repressor of toxins Rot. Two of the mRNA-RNAIII complexes involve fully base paired loop-loop interactions with similar sequences that are cleaved by RNase III at a unique position. We show here that the sequence of the base pairs within the loop-loop interaction is not critical for RNase III cleavage, but that the co-axial stacking of three consecutive helices provides an ideal topology for RNase III recognition. In contrast, RNase III induces several strong cleavages in a regular helix, which carries a sequence similar to the loop-loop interaction. The introduction of a bulged loop that interrupts the regular helix restrains the number of cleavages. This work shows that S. aureus RNase III is able to bind and cleave a variety of RNA-mRNA substrates, and that specific structure elements direct the action of RNase III.

Entities:  

Keywords:  endoribonuclease; gene regulation; loop-loop interaction; processing; regulatory RNA

Mesh:

Substances:

Year:  2012        PMID: 23134978     DOI: 10.4161/rna.22710

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  8 in total

1.  RNase III-mediated processing of a trans-acting bacterial sRNA and its cis-encoded antagonist.

Authors:  Sarah Lauren Svensson; Cynthia Mira Sharma
Journal:  Elife       Date:  2021-11-29       Impact factor: 8.140

2.  RNase III-CLASH of multi-drug resistant Staphylococcus aureus reveals a regulatory mRNA 3'UTR required for intermediate vancomycin resistance.

Authors:  Daniel G Mediati; Julia L Wong; Wei Gao; Stuart McKellar; Chi Nam Ignatius Pang; Sylvania Wu; Winton Wu; Brandon Sy; Ian R Monk; Joanna M Biazik; Marc R Wilkins; Benjamin P Howden; Timothy P Stinear; Sander Granneman; Jai J Tree
Journal:  Nat Commun       Date:  2022-06-22       Impact factor: 17.694

3.  Identification of RNAIII-binding proteins in Staphylococcus aureus using tethered RNAs and streptavidin aptamers based pull-down assay.

Authors:  Xu Zhang; Qing Zhu; Tian Tian; Changlong Zhao; Jianye Zang; Ting Xue; Baolin Sun
Journal:  BMC Microbiol       Date:  2015-05-15       Impact factor: 3.605

Review 4.  Biofilms by bacterial human pathogens: Clinical relevance - development, composition and regulation - therapeutical strategies.

Authors:  Adina Schulze; Fabian Mitterer; Joao P Pombo; Stefan Schild
Journal:  Microb Cell       Date:  2021-02-01

5.  Another layer of complexity in Staphylococcus aureus methionine biosynthesis control: unusual RNase III-driven T-box riboswitch cleavage determines met operon mRNA stability and decay.

Authors:  Freya D R Wencker; Gabriella Marincola; Sonja M K Schoenfelder; Sandra Maaß; Dörte Becher; Wilma Ziebuhr
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

6.  Small RNA teg49 Is Derived from a sarA Transcript and Regulates Virulence Genes Independent of SarA in Staphylococcus aureus.

Authors:  Adhar C Manna; Samin Kim; Liviu Cengher; Anna Corvaglia; Stefano Leo; Patrice Francois; Ambrose L Cheung
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 7.  Emerging functions for the Staphylococcus aureus RNome.

Authors:  Julien Guillet; Marc Hallier; Brice Felden
Journal:  PLoS Pathog       Date:  2013-12-12       Impact factor: 6.823

8.  The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis.

Authors:  Luis Solans; Jesús Gonzalo-Asensio; Claudia Sala; Andrej Benjak; Swapna Uplekar; Jacques Rougemont; Christophe Guilhot; Wladimir Malaga; Carlos Martín; Stewart T Cole
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.